Fortunately, KHDC1L was found to regulate both AKT and Bcl-2 in HNSCC, and it is reasonable to excavate the potential for KHDC1L to be a new therapeutic target. The gene discussed is KHDC1L; the disease is head and neck squamous cell carcinoma.